App-Quantinova.ai

STUDY OF CLINICAL AND PROTHROMBOTIC GENE MUTATION AS PREDICTORS OF THROMBOEMBOLISM IN PEDIATRIC CANCER

Mervat Hesham - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Protein C

MTHFR C677T AND A1298C POLYMORPHISMS INCRESASE THE RISK OF VENOUS THROMBOEMBOLISM BUT NOT ARTERIAL ISCHEMIC EVENTS - A SINGLE CENTER RETROSPECTIVE REVIEW

Jaroslaw Dybko - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

SUPERIOR VENACAVA THROMBOSIS ; A RARE CONSEQUENCE OF BREAST CANCER.

Veerendra Chadachan - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

THERAPY OF CANCER ASSOCIATED THROMBOSIS

Frosina Krstanoska - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

VENOUS THROMBOEMBOLISM AS A MANIFESTATION OF ENDOMETRIAL CANCER

nihar pandit - European Hematology Association (EHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Maternal age and body mass index provide the best target population for venous thromboembolism prevention

Larry E. Shields - Society for Maternal-Fetal Medicine (SMFM) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Venous thromboembolism prophylaxis after cesarean delivery at a tertiary referral center

Laurel Garber - Society for Maternal-Fetal Medicine (SMFM) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Heparin

The impact of mode of delivery on subsequent pregnancy outcomes after periviable birth

Andrea Desai - Society for Maternal-Fetal Medicine (SMFM) , 2019

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Venous thrombosis

N/A

The evidence of anaphylactoid reaction in lung tissue affected by amniotic fluid embolism

Tomoaki Oda - Society for Maternal-Fetal Medicine (SMFM) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Postpartum venous thromboembolism prophylaxis A Cost-Effectiveness Analysis

David A. Becker - Society for Maternal-Fetal Medicine (SMFM) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Enoxaparin

Universal screening of inherited thrombophilias to reduce venous thromboembolism risk in pregnancy a decision analysis

Bethany A. Sabol - Society for Maternal-Fetal Medicine (SMFM) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

N/A

Stroke in pregnancy

Corey Clifford - Society for Maternal-Fetal Medicine (SMFM) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

N/A

Predicting venous thromboembolism in obese pregnant women in a national study

Homa K. Ahmadzia - Society for Maternal-Fetal Medicine (SMFM) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Cost-effectiveness analysis comparing pre-incision and postpartum antibiotics for cesarean infection prophylaxis in obese women

Ashley E. Skeith - Society for Maternal-Fetal Medicine (SMFM) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Metronidazole

Attempting low transverse incision compared with classical incision between 23 and 28 weeks’ gestation.

Tetsuya Kawakita - Society for Maternal-Fetal Medicine (SMFM) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Lower uterine segment ultrasound measurement for deciding about TOLAC a randomized clinical trial

Patrick Rozenberg - Society for Maternal-Fetal Medicine (SMFM) , 2020

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Venous thrombosis

N/A

Severe maternal morbidity in lower-risk pregnancies

Rebecca Simon - Society for Maternal-Fetal Medicine (SMFM) , 2020

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Venous thrombosis

N/A

Obstetric thromboembolism and risk for post-thrombotic syndrome in months and years after delivery

Shravya Govindappagari - Society for Maternal-Fetal Medicine (SMFM) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Trends in thromboembolism as a source of Maternal Mortality

Meike Schuster - Society for Maternal-Fetal Medicine (SMFM) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Is 17-alpha hydroxyprogesterone caproate associated with increased risk for thromboembolism during pregnancy?

Meike Schuster - Society for Maternal-Fetal Medicine (SMFM) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Hydroxyprogesterone caproate

Filters

7277 Abstracts